Art

J-GLOBAL ID：200902211561393551   Reference number：08A0626173

Efficacy and Safety of Pemetrexed in Combination with Cisplatin for Malignant Pleural Mesothelioma: A Phase I/II Study in Japanese Patients

悪性胸膜中皮腫に対するシスプラチンと併用した場合のペメトレキセドの有効性と安全性 日本人患者における第1/2相試験

Author (11)： NAKAGAWA Kazuhiko (Kinki Univ. School of Medicine, Osaka) ,  YAMAZAKI Koichi (Hokkaido Univ. School of Medicine, Sapporo) ,  KUNITOH Hideo (National Cancer Center Hospital, Tokyo) ,  HIDA Toyoaki (Aichi Cancer Center Hospital, Nagoya) ,  GEMBA Kenichi (Okayama Rosai Hospital, Okayama) ,  SHINKAI Tetsu (Shikoku Cancer Center, Matsuyama) ,  ICHINOSE Yukito (National Kyushu Cancer Center, Fukuoka, JPN) ,  ADACHI Susumu (Eli Lilly and co., IN, USA) ,  NAMBU Yoshihiro (Eli Lilly Japan K.K., Kobe) ,  SAIJO Nagahiro (National Cancer Center Hospital East, Chiba, JPN) ,  FUKUOKA Masahiro (Kinki Univ. School of Medicine, Osaka)
Material： Japanese Journal of Clinical Oncology  (JJCO)
Volume： 38  Issue： 5  Page： 339-346  Publication year： May. 2008 
JST Material Number： W2222A  ISSN： 0368-2811  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *mesothelioma ,...
Semi thesaurus term： *悪性胸膜中皮腫 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=08A0626173&from=J-GLOBAL&jstjournalNo=W2222A") }}

JST classification (2)： Drug therapy(=pharmacotherapy)for tumors  (GE03032C) ,  Clinical application of antitumor(=antineoplastic)drugs  (GW16020L)

Substance index (1)： Pemetrexed

Reference (16)：

• British Thoracic Society Standards of Care Committee. Statement on malignant mesothelioma in the United Kingdom. Thorax 2001; 56: 250-65.
• Carter SK. Study design principles in the clinical evaluation of new drugs as developed by the chemotherapy programme of the National Cancer Institute. In: Staquet MJ, editor. The Design of Clinical Trials in Cancer Therapy. Brussels, Belgium: Futara Pub Co 1973; 242-89.
• Cella DF, Bonomi AE, Lloyd SR, Tulsky DS, Kaplan E, Bonomi P. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 1995; 12: 199-220.
• Eguchi K, Kurihara M, Shimozuma K, Hotta T, Murakami M, Suzuki N, et al. Quality of life questionnaire for cancer patients treated with anticancer drugs. Nippon Ganchiryo Gakkaishi 1993; 28: 1140-4 (in Japanese).
• Green S, Weiss GR. Southwest oncology group standard response criteria, endpoint definitions and toxicity criteria. Invest New Drugs 1992; 10: 239-53.

Terms in the title (9)： 悪性胸膜中皮腫 ,  シスプラチン ,  併用 ,  ペメトレキセド ,  有効性 ,  安全性 ,  日本人 ,  患者 ,  試験